Notice

Institut Pasteur Korea holds a High Content Screening(HCS) for Therapeutics Discovery

2024-09-09

Institut Pasteur Korea holds a
High Content Screening(HCS) for Therapeutics Discovery

Institut Pasteur Korea (IPK)'s signature training course, High Content Screening (HCS) for Therapeutics Discovery, was held over five days from August 26 to 30.

The HCS training offers comprehensive education and practical knowledge on the entire HCS process, including cell-based assay development, automated microscope operation, small- and large-scale drug screening, and result analysis, contributing to the development of skilled research personnel.

IPK's signature training course,"High Content Screening (HCS) for Therapeutics Discovery", started on August 28th. The program takes place for five days until September 1st, with a total of 20 researchers and students participating from different nationalities. They receive various education on advanced screening technologies, includingcell-based assay development, automated microscopy utilization, and low-content/high-content screening.

This year, 20 researchers and students from various countries, including France, Italy, Greece, Cambodia, and Cameroon, participated in both theoretical and practical training sessions, sharing their experiences and achievements.

Additionally, IPK's HCS curriculum was acknowledged for its excellence and expertise by being certified as a 'Pasteur International Course (PIC)' last year. This year's training was conducted in collaboration with the Pasteur Network.

Title	Speaker
- Designing & establishing cell-based assays for screening - High Content Assay: instrumentation and assay development - Designing & setting up complex phenotypic assays - Automated microscopy image processing and analysis - High content screening data analysis	Dr. Regis Grailhe, IPK, Head, Technology Development Platform
	Dr. David Shum, IPK, Head, Screening Discovery Platform
	Dr. Haengran Seo, IPK, Head, Advanced BioMedical Research Lab
	Dr. Inhee Choi, IPK, Head, AI Drug Discovery
	Dr. Euiho Kim, IPK, Head, Viral Immunology Lab
	Dr. Timothy Wai, Institut Pasteur, Head, Unit of Mitochondrial Biology
	Dr. Samy Gobaa, Institut Pasteur, Head, Biomaterials and microfluidics core facility
	Prof. Hojung Nam, Professor, School of Electrical Engineering and Computer Science, AI Graduate School, Gwangju Institute of Science and echnology (GIST)

▼ Check out photos from the 5-day training journey!

◆ Day 1 : Designing & establishing cell-based assays for screening

◆ Day 2 : Cell-based assays for screening and ex-vivo models for screening

◆ Day 3 : HCS instrumentation and automation systems

◆ Day 4 : Image processing and screening data analysis

◆ Day 5 : Closing and discussion

LIST